Pieter van der Meer
Pieter van der Meer joined Gilde in 1998 following a consultant position with KPMG Management Consulting. Pieter is founder and managing partner of Gilde Healthcare. He is co-responsible for general management and fundraising of the healthcare technology and services funds.
Pieter is a Dutch national and speaks English and Spanish. He holds a master degree in Chemistry from Leiden University specializing in bio-organic synthesis and molecular modeling. He led investments in Ablynx, Acacia Pharma, Agendia, Inpharmatica, BG Medicine and NightBalance.
He currently serves on the boards of Acacia Pharma and NightBalance and represented Gilde on the boards of Ablynx and BG Medicine until their respective listings at Euronext and NASDAQ.
Pieter was part of the working group of the Dutch Association of Private Equity investors (www.nvp.nl) advising the Ministry of Economic Affairs on venture capital. He is a member of project screening committees with Dutch technology institutes and universities. He also served on the board of the life sciences subcommittee of the European Private Equity & Venture Capital Association (www.evca.eu).